Hagop Kantarjian, MD, interviews Nicholas Short, MD, discuss whether giving blinatumomab immediately after mini-hyper-CVD, rather than in later cycles, can improve outcomes in older adults with ALL. They also explore what this shift could mean for younger patients and the future role of CAR-T in frontline care.
This video was filmed at the Thirteenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2025). Watch more videos from SOHO 2025.
Leave feedback about this